Arrotex Australia Group has been formed in Australia following the completion of the merger between Strides’ Arrow and Apotex’ local unit.
Arrotex Australia Group has been formed by the merger of former Strides business Arrow Pharmaceuticals and Apotex Australia, after the deal – more than a year in the making – closed on 10 July.
The combined company becomes “Australia’s largest generic pharmaceutical and private label OTC business, with around 50% market share of the...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
